171 related articles for article (PubMed ID: 20222179)
1. Rituximab maintenance for follicular lymphoma.
Vidal L; Gafter-Gvili A; Shpilberg O
Nat Rev Clin Oncol; 2010 Mar; 7(3):1; author reply 1. PubMed ID: 20222179
[No Abstract] [Full Text] [Related]
2. Rituximab maintenance therapy in follicular lymphoma comes of age.
Hiddemann W
Leuk Res; 2006 Mar; 30 Suppl 1():S1-2. PubMed ID: 16750672
[No Abstract] [Full Text] [Related]
3. Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab.
Scaramucci L; Perrotti A; Niscola P; Fratoni S; Palombi M; Piccioni D; Cupelli L; Tendas A; Dentamaro T; Del Poeta G; De Fabritiis P
Leuk Lymphoma; 2007 Sep; 48(9):1878-80. PubMed ID: 17786731
[No Abstract] [Full Text] [Related]
4. Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study.
Askeland G
Expert Rev Clin Immunol; 2013 May; 9(5):402. PubMed ID: 23772446
[No Abstract] [Full Text] [Related]
5. Rituximab maintenance therapy in indolent NHL: a clinical review.
Buske C; Hiddemann W
Leuk Res; 2006 Mar; 30 Suppl 1():S11-5. PubMed ID: 16750673
[TBL] [Abstract][Full Text] [Related]
6. Rituximab as first-line maintenance therapy following rituximab-containing therapy for follicular lymphoma: profile report.
Croxtall JD
BioDrugs; 2011 Oct; 25(5):329-31. PubMed ID: 21942917
[No Abstract] [Full Text] [Related]
7. What is the role of maintenance rituximab in follicular NHL?
Maloney DG
Oncology (Williston Park); 2008 Jan; 22(1):20-6; discussion 26, 29, 33-4. PubMed ID: 18251281
[TBL] [Abstract][Full Text] [Related]
8. Primary duodenal follicular lymphoma successfully treated with rituximab.
Aguiar-Bujanda D; Quiñones-Morales I; Camacho-Galán R; Llorca-Martínez I; Rivero-Vera JC; Bohn-Sarmiento U; Aguiar-Morales J
Clin Transl Oncol; 2007 Jul; 9(7):471-2. PubMed ID: 17652063
[TBL] [Abstract][Full Text] [Related]
9. Variation in gene expression patterns in follicular lymphoma and the response to rituximab.
Bohen SP; Troyanskaya OG; Alter O; Warnke R; Botstein D; Brown PO; Levy R
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1926-30. PubMed ID: 12571354
[TBL] [Abstract][Full Text] [Related]
10. Rituximab by subcutaneous route.
Solal-Celigny P
Expert Rev Hematol; 2015 Apr; 8(2):147-53. PubMed ID: 25749209
[TBL] [Abstract][Full Text] [Related]
11. Optimization of postremission therapy in follicular lymphoma: efficacy of rituximab maintenance.
Roy R; Gordon LI
J Natl Compr Canc Netw; 2011 May; 9(5):563-71. PubMed ID: 21550969
[TBL] [Abstract][Full Text] [Related]
12. Maintenance rituximab should be considered for patients with follicular lymphoma.
Barr PM
Clin Adv Hematol Oncol; 2014 Aug; 12(8):541-3. PubMed ID: 25356579
[No Abstract] [Full Text] [Related]
13. A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma.
Racila E; Link BK; Weng WK; Witzig TE; Ansell S; Maurer MJ; Huang J; Dahle C; Halwani A; Levy R; Weiner GJ
Clin Cancer Res; 2008 Oct; 14(20):6697-703. PubMed ID: 18927313
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma.
Boland A; Bagust A; Hockenhull J; Davis H; Chu P; Dickson R
Health Technol Assess; 2009 Sep; 13 Suppl 2():41-8. PubMed ID: 19804688
[TBL] [Abstract][Full Text] [Related]
15. Rituximab maintenance therapy for follicular lymphoma.
Haines I
Lancet; 2011 Apr; 377(9772):1151; author reply 1151-2. PubMed ID: 21459205
[No Abstract] [Full Text] [Related]
16. Rituximab maintenance versus radio-immunotherapy consolidation in first remission follicular non-Hodgkin lymphoma.
Hagenbeek A
Transfus Apher Sci; 2013 Aug; 49(1):43. PubMed ID: 23932512
[No Abstract] [Full Text] [Related]
17. Rituximab for follicular non-Hodgkin lymphoma.
Gajraj E; Chung H; Longson C; Stevens A
Lancet Oncol; 2008 Apr; 9(4):320-1. PubMed ID: 18405852
[No Abstract] [Full Text] [Related]
18. Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma.
Sanchez-Gonzalez B; Gimeno E; Garcia-Pallarols F; Ancochea A; Salar A
Leuk Lymphoma; 2014 Oct; 55(10):2384-6. PubMed ID: 24601815
[No Abstract] [Full Text] [Related]
19. Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's lymphoma: a systematic review and economic evaluation.
Wake B; Hyde C; Bryan S; Barton P; Song F; Fry-Smith A; Davenport C
Health Technol Assess; 2002; 6(3):1-85. PubMed ID: 12022936
[No Abstract] [Full Text] [Related]
20. Considerations with newer regimens for indolent non-Hodgkin lymphoma.
Rummel M
Clin Lymphoma Myeloma; 2008 Aug; 8 Suppl 4():S128-36. PubMed ID: 18952543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]